Summary
Updated Aug 31, 2026
James Basta is EVP, General Counsel of Intellia Therapeutics, Inc. (NTLA). 2 SEC Form 4 filings on record, most recently on 3 March 2026. Most recent open-market trade: sold $17K of NTLA on 3 March 2026. Lifetime open-market sales: $112K.
Recent Transactions
3Every recent SEC Form 4 transaction James Basta has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies James Basta files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- John M. Leonard - $1.44M of NTLA open-market activity in the last 12 months
- Fred E. Cohen - $1.40M of NTLA open-market activity in the last 12 months
- Edward J. Dulac III - $234K of NTLA open-market activity in the last 12 months
- David Lebwohl - $110K of NTLA open-market activity in the last 12 months
- Michael P. Dube - $104K of NTLA open-market activity in the last 12 months
- Eliana Clark - $96K of NTLA open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is James Basta?
James Basta is a corporate insider, tracked as EVP, General Counsel of Intellia Therapeutics, Inc. (NTLA). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did James Basta last file a Form 4?
The most recent primary Form 4 on record is dated 3 March 2026, one of 2 filings going back to 2026.
Has James Basta been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($112K) across all tracked filings.
Where can I see all of James Basta's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow James Basta and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
